What are you looking for?

Our four smoke-free platforms

Our platforms are at different stages of development and commercialization.

Products Platform 1 Heated Tobacco Product Platform 2 Heated Tobacco Product Platform 3 Nicotine-Containing E-Vapor Platform 4 Nicotine Containing E-Vapor

Technology

 Heated Tobacco Product

Learn more about Platform1

Also referred to as EHTP or THS		 Heated Tobacco Product

Learn more about Platform 2

Also referred to as CHTP		 E-Vapor

Learn more about Platform 3		 E-Vapor

Learn more about Platform 4

Nicotine Source

 Tobacco Tobacco Nicotine salt E-liquid

Max Temperature

 below 350° C

(cigarettes up to 900° C)		 below 350° C

(cigarettes up to 900° C)		 100° C 200-220° C

Heat Source & Battery

 Electronically controlled ceramic heat-blade

Li-ion

 Charcoal

None

 Electronically controlled heater

Li-ion

 Electronically controlled MESH heater

Li-ion

Our findings to date

 Average of 95% reduction of levels of HPHCs*

Average of 90-95% reduction in toxicity*		 Average of 90-95% reduction of levels HPHCs*

Average of 90-95% reduction in toxicity		 Ongoing Ongoing

A reduction in biomarkers of exposure similar to levels found in smoking cessation.

Favorable changes in health indicators upon switching to Platform 1**.

 A reduction in biomarkers of exposure similar to levels found in smoking cessation.** Planned for 2018

Intent to use among non-smokers up to 6.4%, among adult smokers up to 39%

Post-market surveillance ongoing

 Perception and behavior study ongoing Planned for 2018 Planned for 2018

commercialization

 Yes Yes No Yes

*Compared to a standard 3R4F cigarette used for research purposes

**Compared to continued smoking

 

*The products depicted are subject to ongoing development and therefore visuals are illustrative and do not necessarily represent the latest stages of product development.


Why is combustion harmful?

Read why

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products (“RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.